Imatinib is a drug used to treat certain types of leukemia, a cancer of the blood and bone marrow. It is a tyrosine kinase inhibitor, meaning it works by blocking the action of certain enzymes that are involved in the growth and spread of cancer cells. Imatinib is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It is also used to treat certain types of gastrointestinal stromal tumors (GISTs). Imatinib is available in both generic and brand-name forms. Imatinib is a widely used drug in the treatment of leukemia, and is often prescribed as a first-line treatment for CML and GISTs. It is generally well-tolerated and has been shown to be effective in controlling the disease and prolonging survival. Some companies in the Imatinib market include Novartis, Pfizer, and Cipla. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
